USD/CAD plunged on Wednesday amid rising Fed rate cut expectations, but strong support at 1.40 suggests the broader uptrend could resume after holiday-related volatility subsides.
Full FDA approval for one of its drugs, an excellent earnings report, and a deep pipeline support the bullish trend. Is there more room to the upside for Amgen?